FI964339A0 - Enzymbehandling av glukaner - Google Patents

Enzymbehandling av glukaner

Info

Publication number
FI964339A0
FI964339A0 FI964339A FI964339A FI964339A0 FI 964339 A0 FI964339 A0 FI 964339A0 FI 964339 A FI964339 A FI 964339A FI 964339 A FI964339 A FI 964339A FI 964339 A0 FI964339 A0 FI 964339A0
Authority
FI
Finland
Prior art keywords
glucan
yeast
glucans
enzyme treatment
yeast cell
Prior art date
Application number
FI964339A
Other languages
English (en)
Finnish (fi)
Other versions
FI114807B (sv
FI964339A (sv
Inventor
Rolf Engstad
Finn Kortner
Borre Robertsen
Gunnar Rorstad
Original Assignee
Biotec Mackzymal As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19897060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI964339(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotec Mackzymal As filed Critical Biotec Mackzymal As
Publication of FI964339A publication Critical patent/FI964339A/sv
Publication of FI964339A0 publication Critical patent/FI964339A0/sv
Application granted granted Critical
Publication of FI114807B publication Critical patent/FI114807B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI964339A 1994-04-29 1996-10-28 Enzymbehandling av glukaner FI114807B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NO941581A NO300692B1 (no) 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
NO941581 1994-04-29
PCT/IB1995/000265 WO1995030022A1 (en) 1994-04-29 1995-04-18 Enzyme treatment of glucans
IB9500265 1995-04-18

Publications (3)

Publication Number Publication Date
FI964339A FI964339A (sv) 1996-10-28
FI964339A0 true FI964339A0 (sv) 1996-10-28
FI114807B FI114807B (sv) 2004-12-31

Family

ID=19897060

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964339A FI114807B (sv) 1994-04-29 1996-10-28 Enzymbehandling av glukaner

Country Status (12)

Country Link
US (3) US7883875B2 (sv)
EP (1) EP0759089B1 (sv)
JP (3) JP3992730B2 (sv)
AT (1) ATE222958T1 (sv)
AU (1) AU703251B2 (sv)
CA (1) CA2189010C (sv)
DE (1) DE69527955T2 (sv)
DK (1) DK0759089T3 (sv)
ES (1) ES2182898T3 (sv)
FI (1) FI114807B (sv)
NO (1) NO300692B1 (sv)
WO (1) WO1995030022A1 (sv)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300692B1 (no) * 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
DE19911055A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Verwendung von oberflächenaktiven Gemischen
DE19911053B4 (de) 1999-03-12 2004-10-28 Biotec Asa Kosmetische und/oder pharmazeutische Zubereitungen
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen
US8501710B2 (en) * 1999-03-12 2013-08-06 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
DE19911058B4 (de) * 1999-03-12 2004-09-30 Biotec Asa Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
US6875754B1 (en) 1999-03-12 2005-04-05 Biotec Asa Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents
US8912165B2 (en) 1999-03-12 2014-12-16 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
DE19911052A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sonnenschutzmittel
DE19917744A1 (de) * 1999-04-20 2000-10-26 Cognis Deutschland Gmbh Dekorative kosmetische Zubereitungen
DE19917743C2 (de) * 1999-04-20 2003-08-14 Biotec Asa Desodorierende Zubereitungen
DE19920557B4 (de) * 1999-05-05 2004-09-09 Biotec Asa Verfahren zur Herstellung von Kollagenfreien kosmetischen Zubereitungen
US20020009463A1 (en) * 2000-02-23 2002-01-24 Jan Raa Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
GB0211118D0 (en) 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050180964A1 (en) 2003-03-17 2005-08-18 Puntenney Steven B. Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
JP2004210895A (ja) * 2002-12-27 2004-07-29 Immudyne Japan:Kk 免疫機能を有する可能性β−グルカンの製造方法及び用途
ATE426037T1 (de) 2004-02-13 2009-04-15 Alpron Co Ltd Verfahren zur herstellung von aus hefe stammendem glucan
US20050220846A1 (en) 2004-04-05 2005-10-06 Puntenney Steven B Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
AU2004218698B2 (en) * 2004-10-08 2011-06-09 Biotec BetaGlucans AS Method
JP4570949B2 (ja) * 2004-12-13 2010-10-27 株式会社アルプロン 酵母由来グルカンの製造方法
WO2007021262A1 (en) * 2005-08-10 2007-02-22 Steven Bruce Puntenney USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
JP2009528267A (ja) * 2006-01-17 2009-08-06 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ 治療を増強するグルカン
US8142798B2 (en) 2006-04-26 2012-03-27 OmniGen Research, L.L.C. Augmentation of titer for vaccination in animals
US9457047B2 (en) 2006-11-06 2016-10-04 Whitehead Institute Immunomodulating compositions and methods of use thereof
US8580253B2 (en) * 2006-11-06 2013-11-12 Whitehead Institute Immunomodulating compositions and methods of use
WO2008102151A1 (en) * 2007-02-21 2008-08-28 Biotec Pharmacon Asa Medical uses of glucans
MY150220A (en) * 2007-05-08 2013-12-31 Biothera Inc Particulate-soluble glucan preparation
FI20070471A0 (sv) * 2007-06-13 2007-06-13 Glykos Finland Oy Näringstillskottskompositioner
CA2705544A1 (en) * 2007-11-19 2009-05-28 Calanus As Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
ES2599908T3 (es) * 2007-11-26 2017-02-06 Glaxosmithkline Biologicals Sa Glucanos beta-1,3-enlazados conjugados
BRPI0900639C1 (pt) * 2009-02-13 2011-12-20 Hebron Farmaceutica Pesquisa Desenvolvimento E Inovacao Tecnologica Ltda composição farmacêutica e uso desta para tratamento e/ou prevenção de doenças do trato respiratório
ES2873502T3 (es) 2009-03-27 2021-11-03 Bend Res Inc Proceso de secado por pulverización
JP5242855B2 (ja) * 2010-07-29 2013-07-24 国立大学法人北海道大学 免疫アジュバント
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
WO2012031133A2 (en) 2010-09-03 2012-03-08 Bench Research, Inc. Spray-drying apparatus and methods of using the same
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
GB201020193D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
GB201020191D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan gels
GB201020190D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucans
EP2694030A2 (en) 2011-03-04 2014-02-12 Sana Pharma AS Cosmetic formulations
FR2981075A1 (fr) 2011-10-11 2013-04-12 Kitozyme Procede de preparation de glucans a partir d'aspergillus niger
MD4329C1 (ro) * 2013-10-30 2015-09-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Procedeu de cultivare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20
PT3110437T (pt) 2014-02-12 2018-01-16 Omnigen Res Llc Composição e método para promover a redução do stress térmico em animais
US11364203B2 (en) 2014-10-31 2022-06-21 Bend Reserch, Inc. Process for forming active domains dispersed in a matrix
CA2997553A1 (en) 2015-09-09 2017-03-16 Omnigen Research, Llc A particulate composition comprising silica, mineral clay, glucan and mannans for aquaculture

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2764463A (en) 1953-05-26 1956-09-25 Underwood Corp Magnetic recording system
US3954979A (en) * 1972-11-24 1976-05-04 Ceres Products Company, Inc. Process for preparing stabilized yeast and compositions and tableting composition and method
JPS5432076B2 (sv) 1973-09-14 1979-10-11
JPS54138115A (en) * 1978-04-17 1979-10-26 Kirin Brewery Antiicancer agent
GB2076418A (en) 1980-05-22 1981-12-02 Sankyo Co Hydrolyzed polysaccharide
JPS6019619B2 (ja) 1980-09-19 1985-05-17 株式会社日立製作所 Ｘ線管用回転陽極
SE456911B (sv) * 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
JPS60196195A (ja) 1984-03-21 1985-10-04 Dainippon Seito Kk イ−ストグルカンの製造法
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5028703A (en) * 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4810646A (en) * 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5082936A (en) * 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5057503A (en) * 1989-01-23 1991-10-15 The Brigham And Women's Hospital Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor
CA1330303C (en) * 1989-02-20 1994-06-21 Libor Henry Nikl Composition and process to enhance the efficacy of a fish vaccine
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
JPH05503952A (ja) * 1989-09-08 1993-06-24 アルファ　ベータ　テクノロジー，インコーポレイティッド 可溶性グルカン類の製造方法
WO1991003248A2 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for immune system activation
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan

Also Published As

Publication number Publication date
US20110104208A1 (en) 2011-05-05
CA2189010A1 (en) 1995-11-09
FI114807B (sv) 2004-12-31
JP3992730B2 (ja) 2007-10-17
CA2189010C (en) 2010-07-13
FI964339A (sv) 1996-10-28
DK0759089T3 (da) 2003-01-06
EP0759089A1 (en) 1997-02-26
US20050255565A1 (en) 2005-11-17
WO1995030022A1 (en) 1995-11-09
AU703251B2 (en) 1999-03-25
US8142785B2 (en) 2012-03-27
JP2009051863A (ja) 2009-03-12
US8252295B2 (en) 2012-08-28
NO300692B1 (no) 1997-07-07
DE69527955D1 (de) 2002-10-02
NO941581D0 (sv) 1994-04-29
NO941581L (no) 1995-10-30
US20080124349A1 (en) 2008-05-29
ES2182898T3 (es) 2003-03-16
US7883875B2 (en) 2011-02-08
DE69527955T2 (de) 2003-04-10
AU2146495A (en) 1995-11-29
ATE222958T1 (de) 2002-09-15
JPH09512708A (ja) 1997-12-22
JP2007228974A (ja) 2007-09-13
EP0759089B1 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
FI964339A (sv) Enzymbehandling av glukaner
ATE71528T1 (de) Loesliches phosphoryliertes glukan.
AU8596791A (en) Yeast
WO1998051712A1 (fr) Billes de chitine, billes de chitosane, leurs procedes de fabrication, supports obtenus a partir de ces billes et procedes de production de spores de microsporidies
ES8104407A1 (es) Un metodo de produccion de etanol
KR890700658A (ko) 아스타크산틴-생산 효모 세포, 그의 제조방법 및 용도
Kim et al. Immunomodulating activity of a polysaccharide isolated from Mori Cortex Radicis
DE69431162D1 (en) Fenbendazolformulierungen
AU2001243667A1 (en) Method of aerating yeast prior to pitching
Kozhemyakina et al. Conditions of cultivation, composition, and biological activity of mycelium of Flammulina velutipes (Fr.) P. Karst
JPS6442412A (en) Skin-beautifying cosmetic
ES8506083A1 (es) Procedimiento para preparar l-aminoacido-oxidasas
IN2002DE00216A (sv)
WO2001026801A8 (en) Composition of matter tailoring: system i
EP1237093A3 (en) Methods and apparatus for associating character codes with optimized character codes
KR880011048A (ko) 분뇨 발효제
钮学新 et al. Dynamic-statistic method for forecasting the intensity of tropical cyclone
FR2300806A1 (fr) Procede de fabrication de produits riches en proteines
Rusinov Linear selection of highly productive strains of Penicillium chrysogenum
Rowen GLC3: The gene encoding the glycogen branching enzyme of Saccharomyces cerevisiae
Janusz et al. Isolation of a unit ligand for β-glucan receptors of human monocytes
UA11935A1 (uk) Гібридhий штам дріжджів sассhаrомyсеs сеrеvіsіае, який використовується для одержання хлібопекарських дріжджів
PE20020313A1 (es) Nueva mezcla de oligosacaridos no sulfatados a base de fucosa, composicion cosmetica o farmaceutica que la comprende
MY124118A (en) Organometallic-metabolizing yeast
AMBROSIAE Ñïîðîâ³ ðîñëèíè òà ãðèáè

Legal Events

Date Code Title Description
MM Patent lapsed